Following the news from Florida

Provided by AGP

Florida Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Gazette.

Press releases published on May 7, 2026

The Peach Cobbler Factory Continues Major Southern Expansion With New Tallahassee Location
Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
Thomas Mollick Scholarship for Entrepreneurs Opens 2026 Application Cycle for Undergraduate Business Founders
Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting
Team Pegine Inc Unveils Report on Hidden Costs in Critical Infrastructure Leadership
Lov MedSpa Miami Establishes Consistent Five-Star Standard in Aventura and North Miami Beach Medical Spa Market
Tampa Fast Home Buyer Reports Growth in Time-Driven Property Sales
Serotonin Centers Highlights 5-Day Live Training Program as Cornerstone of Franchise Support and Performance
CELFULL to Unveil Celfavor Advanced Anti-Aging Delivery Technology at Vitafoods 2026
King Bach Sets YouTube Comedy Special, 'Like, Share, and Comment'
Standard Dental Labs Inc. Closes Acquisition of BRLIT Dental Laboratory, Increasing Revenue Base by More Than 375%
HotelPlanner Launches TicketPlanner and Appoints Industry Veteran Paul Bausch to Lead Customer-First Ticketing Platform
Streamex Corp. to Present at the 21st Annual Needham Technology, Media, & Consumer Conference
Duos Edge AI to Host Victoria Edge Data Center Open House
Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA
Innventure to Announce First Quarter 2026 Results on May 14, 2026
XTEND Secures $8.25 Million Order, Marking Continued Expansion of Autonomous Drone Programs Across Europe
AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential
Regency Centers Declares Quarterly Dividends

Share us

on your social networks:

Sign up for:

Florida Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.